Добавил:

Sekretar kiopkiopkiop18@yandex.ru t.me/Prokururor I Вовсе не секретарь, но почту проверяю Опубликованный материал нарушает ваши авторские права? Сообщите нам.

Вуз:

Ростовский Государственный Медицинский Университет

Предмет:

Медицина общая

Файл:

Книга_5698_Библиотеки_им_академика_М_И_Перельмана

.pdf

Скачиваний:

Добавлен:

12.10.2026

Размер:

7 Мб

Скачать

☆

<<< < Предыдущая 10 11 12 13 14 15 16 17 18 19 20 2122 / 4922 23 24 25 26 27 28 29 30 31 32 33 34 > Следующая >>>

[4] Dourado D, Freire DT, Pereira DT, Amaral-Machado L, Alencar ÉN, de Barros ALB, et al. Will curcumin nano-

systems be the next promising antiviral alternatives in COVID-19 treatment trials? Biomedicine & Pharmaco-

therapy 2021:139.

[5] Rahman HS, Othman HH, Hammadi NI, Yeap SK, Amin KM, Samad NA, et al. Novel drug delivery systems

for loading of natural plant extracts and their biomedical applications. International Journal of Nanomedicine

2020;15:2439e83.

[6] Teja PK, Mithiya J, Kate AS, Bairwa K, Chauthe SK. Herbal nanomedicines: recent advancements, challenges,

opportunities and regulatory overview. Phytomedicine February 1, 2022;96:153890.

[7] Mirzaei H, Naseri G, Rezaee R, Mohammadi M, Banikazemi Z, Mirzaei HR, et al. Curcumin: A new candidate

for melanoma therapy? International journal of cancer 2016;139(8):1683e95.

[8] Antibiotic resistance responsedGARDP. Available from: https://gardp.org/what-we-do/antibiotic-

resistance/?gclid¼CjwKCAjwsfuYBhAZEiwA5a6CDNCLjd0rSfED19Zhc7rrJ4zfr-

BjrzLn1Zg5kjpYQOko4p0LHIwRJBoCm18QAvD_BwE. (Accessed 12 September 2022).

[9] McGuire S. World cancer report 2014. Geneva, Switzerland: World Health Organization, international agency

for research on cancer, WHO Press, 2015. Advances in Nutrition 2016;7(2):418e9.

[10] Nalbandian A, Sehgal K, Gupta A, Madhavan MV, McGroder C, Stevens JS, et al. Post-acute COVID-19 syn-

drome. Nature Medicine 2021;27(4):601e15. https://doi.org/10.1038/s41591-021-01283-z.

[11] Bozkurt B, Kamat I, Hotez PJ. Myocarditis with COVID-19 mRNA vaccines. Circulation 2021;144:471e84.

[12] Basu D, Chavda VP, Mehta AA. Therapeutics for COVID-19 and post COVID-19 complications: an update.

Current Research in Pharmacology and Drug Discovery January 1, 2022;3:100086.

[13] Chen H, Zhang W, Zhu G, Xie J, Chen X. Rethinking cancer nanotheranostics. Nature Reviews Materials

2017;2.

[14] Yadav SK. Nanoscale materials in targeted drug delivery, theragnosis and tissue regeneration. 2016.

[15] Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nature Materials

2013;12(11):991e1003. https://doi.org/10.1038/nmat3776.

[16] Guerrero S, Inostroza-Riquelme M, Contreras-Orellana P, Diaz-Garcia V, Lara P, Vivanco-Palma A, et al. Cur-

cumin-loaded nanoemulsion: a new safe and effective formulation to prevent tumor reincidence and metas-

tasis. Nanoscale 2018;10(47):22612e22.

[17] Aw YZ, Lim HP, Low LE, Surjit Singh CK, Chan ES, Tey BT. Cellulose nanocrystal (CNC)-stabilized Pickering

emulsion for improved curcumin storage stability. LWT April 1, 2022;159:113249.

[18] Kou L, Sun J, Zhai Y, He Z. The endocytosis and intracellular fate of nanomedicines: implication for rational

design. Asian Journal of Pharmaceutical Sciences 2013;8(1):1e10. https://doi.org/10.1016/j.ajps.2013.07.001.

[19] Martínez-Ballesta M, Gil-Izquierdo Á, García-Viguera C, Domínguez-Perles R. Nanoparticles and controlled

delivery for bioactive compounds: outlining challenges for new “smart-foods” for health. Foods 2018;7(5):72.

https://doi.org/10.3390/foods7050072.

[20] La RHDE. Pedro Gargantillavol. 1; 2012. p. 67e8.

[21] Jamshidi-Kia F, Lorigooini Z, Amini-Khoei H. Medicinal plants: past history and future perspective. Journal of

Herbmed Pharmacology 2018;7(1):1e7.

[22] Ramawat KG, Dass S, Mathur M. Herbal drugs: ethnomedicine to modern medicine. 2009.

[23] Dillehay, T.D., 2005. Monte Verde: Un asentamiento humano del pleistoceno tardío en el sur de Chile. Chun-

gara, Revista de Antropología Chilena 37(2), 275-276. dx.doi.org/10.4067/S0717-73562005000200015.

[24] Bengoa J. Historia de los antiguos mapuches del sur: desde antes de la llegada de los españoles hasta las Paces

de Quilín, siglos XVI y XVII. 2008. p. 524.

[25] World Health Organization (WHO). WHO traditional medicine strategy 2014e2023. World Health Organiza-

tion; 2013. p. 1e76. Available from: http://apps.who.int/iris/bitstream/10665/92455/1/9789241506090_eng.

pdf?ua¼1. [Accessed 9 September 2016].

[26] Jones AW. Early drug discovery and the rise of pharmaceutical chemistry. Drug Testing and Analysis

2011;3(6):337e44.

[27] Waddell WJ. History of dose response. Journal of Toxicological Sciences 2010;35(1):1e

[28] Ramon G. Sur le pouvoir ﬂoculant et sur les proprietes immunisantes d’une toxin diphterique rendu anatox-

ique (anatosine). CR Acad Sci Paris 1923;177:1338e40.

[29] Rosales-Mendoza S, González-Ortega O. Nanovaccines: an innovative technology to ﬁght human and animal

diseases. Nanovaccines: An Innovative Technology to Fight Human and Animal Diseases 2019:1e343.

7. Application of nanomedicine for efﬁcient delivery of herbal bioactives188

https://t.me/med1917

[30] Murphy LL, Ferraro JS. Herbal drugs: ethnomedicine to modern medicine. 2009.

[31] Feynman, RP. There’s plenty of room at the bottom. Engineering and Science Magazine 1961;XXIII(5):22e36.

[32] Jaithliya T, Sehgal S, Noorani Z, Hamid A, Rather MA. Biomedical European of and pharmaceutical sciences.

Nanotechnology: Beginning of New Generation 2018;5(5):932e40.

[33] Biswas AK, Islam MR, Choudhury ZS, Mostafa A, Kadir MF. Nanotechnology based approaches in cancer ther-

apeutics. Advances in Natural Sciences: Nanoscience and Nanotechnology 2014;5(4).

[34] Yarnell E. Artemisia annua (sweet annie), other artemisia species, artemisinin, artemisinin derivatives, and ma-

laria. Journal of Restorative Medicine 2014;3(1):69e84.

[35] Yeshi K, Crayn D, Ritmejeryt

e E, Wangchuk P. Plant secondary metabolites produced in response to abiotic

stresses has potential application in pharmaceutical product development. Molecules 2022;27(1).

[36] Bhakuni DS, Bittner M, Marticorena C, Silva M, Weldt E, Hoeneisen M. Screening of Chilean plants for anti-

cancer activity. I. Lloydia July 1, 1976;39(4):225e43. https://europepmc.org/article/med/957912.

[37] Jofré I, Pezoa C, Cuevas M, Scheuermann E, Freires IA, Rosalen PL, et al. Antioxidant and vasodilator activity

of Ugni molinae Turcz. (murtilla) and its modulatory mechanism in hypotensive response. Oxidative Medicine

and Cellular Longevity 2016;2016.

[38] Erb M, Kliebenstein DJ. Topical review plant secondary metabolites as defenses, regulators, and primary me-

tabolites: the blurred functional trichotomy 1. Plant Physiology 2020;184:39e52. www.plantphysiol.org/cgi/

doi/10.1104/pp.20.00433.

[39] Raven PH, Evert RF, Eichhorn SE. Biology of plants. 7th ed. New York: W. H. Freeman; 2005. In press.

[40] Bohlin L. Natural products isolation. Drug Discovery Today 1998;3(12):536e7.

[41] Nn A. A review on the extraction methods use in medicinal plants, principle, strength and limitation. Medicinal

& Aromatic Plants 2015;04(03):3e8.

[42] Gupta A, Naraniwal M, Kothari V. Modern extraction methods for preparation of bioactive. Plant Extracts

2012;1(1):8e26.

[43] Azmir J, Zaidul ISM, Rahman MM, Sharif KM, Mohamed A, Sahena F, et al. Techniques for extraction of bioac-

tive compounds from plant materials: a review. Journal of Food Engineering 2013;117(4):426e36. https://

doi.org/10.1016/j.jfoodeng.2013.01.014.

[44] Moon G-H, Lee Y, Kim E-K, Chung K-H, Lee K-J, An J-H, et al. Immunomodulatory and anti-inﬂammatory

effects of asiatic acid in a DNCB-induced atopic dermatitis animal model. Nutrients 2021;13(7):2448.

https://doi.org/10.3390/nu13072448.

[45] Fargas C, Lastra J, Hoffmann A. Plantas medicinales de uso común en Chile. Ediciones Paesmi, Chile. Ediciones

Paesmi; 1998.

[46] Muñoz O, Christen P, Cretton S, Backhouse N, Torres V, Correa O, et al. Chemical study and anti-inﬂamma-

tory, analgesic and antioxidant activities of the leaves of Aristotelia chilensis (Mol.) Stuntz, Elaeocarpaceae. Jour-

nal of Pharmacy and Pharmacology 2011;63(6):849e59.

[47] Cespedes CL, Pavon N, Dominguez M, Alarcon J, Balbontin C, Kubo I, et al. The chilean superfruit black-berry

Aristotelia chilensis (Elaeocarpaceae), Maqui as mediator in inﬂammation-associated disorders. Food and

Chemical Toxicology 2017;108:438e50. https://doi.org/10.1016/j.fct.2016.12.036.

[48] Kubitzki K, Rohwer J, Bittrich V. The families and genera of vascular plants. v9. Berlin: Springer; 2007. In press.

[49] Zin J WC. La salud por medio de las plantas medicinales. 1980. Available from: https://scholar.google.com/

scholar?hl¼en&as_sdt¼0%2C5&q¼ZinþJ%2C

þW.þC.%2Cþ1980.þLaþsaludþporþmedioþdeþlasþplantasþ

medicinales.þSantiagoþdeþChile%3AþSalesiana.&btnG¼. [Accessed 12 September 2022].

[50] Fleck JD, Betti AH, Pereira da Silva F, Troian EA, Olivaro C, Ferreira F, et al. Saponins from Quillaja saponaria

and Quillaja brasiliensis: particular chemical characteristics and biological activities. Molecules 2019;24(1).

[51] Rodríguez-Díaz M, Delporte C, Cartagena C, Cassels BK, González P, Silva X, et al. Topical anti-inﬂammatory

activity of quillaic acid from Quillaja saponaria Mol. and some derivatives. Journal of Pharmacy and Pharma-

cology 2011;63(5):718e24.

[52] Jain AK, Thareja S. In vitro and in vivo characterization of pharmaceutical nanocarriers used for drug delivery.

Artiﬁcial Cells, Nanomedicine, and Biotechnology 2019;47(1):524e39. https://doi.org/10.1080/

21691401.2018.1561457.

References 189

https://t.me/med1917

[53] Gismondi A, Reina G, Orlanducci S, Mizzoni F, Gay S, Terranova ML, et al. Nanodiamonds coupled with plant

bioactive metabolites: a nanotech approach for cancer therapy. Biomaterials 2015;38:22e35. https://doi.org/

10.1016/j.biomaterials.2014.10.057.

[54] Khan A, Xiangyang S, Ahmad A, Eng XM-SJB, 2018 undeﬁned. Electrospinning of crude plant extracts for anti-

bacterial and wound healing applications: a review. smjournals.org. Available from: https://smjournals.org/

biomedical-engineering/fulltext/smjbe-v4-1024.pdf. (Accessed 6 September 2022).

[55] Warowicka A, Nawrot R. Pharmacologically active compounds from latex-bearing plantsvol 93; 2020.

[56] Jong WH De, Paul JB. Drug delivery and nanoparticles: applications and hazards. International Journal of

Nanomedicine 2008;3(2):133e49.

[57] Wang M, Hu H, Sun Y, Qiu L, Zhang J, Guan G, et al. A pH-sensitive gene delivery system based on folic acid-

PEG-chitosan-PAMAM-plasmid DNA complexes for cancercelltargeting. Biomaterials 2013;34(38):10120e32.

https://doi.org/10.1016/j.biomaterials.2013.09.006.

[58] Sakhrani NM, Padh H. Organelle targeting: third level of drug targeting. Drug Design, Development and Ther-

apy 2013;7:585e99.

[59] Conte A, Sigismund S. Chapter sixdthe ubiquitin network in the control of EGFR endocytosis and signaling.

In: Progress in Molecular Biology and Translational Science. vol 141. Elsevier Inc.; 2016. p. 225e76.

[60] Nelemans LC, Gurevich L. Drug delivery with polymeric nanocarriers-cellular uptake mechanisms. Materials

(Basel) 2020;13(2):1e21.

[61] Sowa G. Caveolae, caveolins, cavins, and endothelial cell function: new insights. Frontiers in Physiology

2012;2:1e13.

[62] Nel, AE, Mädler, L, Velegol, D, Xia, T, Hoek, E, Somasundaran, P, et al. Understanding biophysicochemical

interactions at the nanoebio interface. Nature Materials 2009;8(7):543e57. https://doi.org/10.1038/nmat2442.

[63] Misra R, Acharya S, Sahoo SK. Cancer nanotechnology: application of nanotechnology in cancer therapy. Drug

Discovery Today 2010;15(19e20):842e50. https://doi.org/10.1016/j.drudis.2010.08.006.

[64] Adjei IM, Peetla C. Heterogeneity in nanoparticles inﬂuences biodistribution and targeting research article.

2013. p. 267e78.

[65] Ehrlich M, Boll W, Van Oijen A, Hariharan R, Chandran K, Nibert ML, et al. Endocytosis by random initiation

and stabilization of clathrin-coated pits. Cell 2004;118(5):591e605.

[66] Cureton DK, Massol RH, Saffarian S, Kirchhausen TL, Whelan SPJ. Vesicular stomatitis virus enters cells

through vesicles incompletely coated with clathrin that depend upon actin for internalization. PLoS Pathogens

2009;5(4).

[67] Suen WLL, Chau Y. Size-dependent internalisation of folate-decorated nanoparticles via the pathways of cla-

thrin and caveolae-mediated endocytosis in ARPE-19 cells. Journal of Pharmacy and Pharmacology

2014;66(4):564e73.

[68] Debbage P, Jaschke W. Molecular imaging with nanoparticles: giant roles for dwarf actors. Histochemistry and

Cell Biology 2008;130(5):845e75.

[69] Vilella A, Tosi G, Grabrucker AM, Ruozi B, Belletti D, Vandelli MA, et al. Insight on the fate of CNS-targeted

nanoparticles. Part I: Rab5-dependent cell-speciﬁc uptake and distribution. Journal of Controlled Release

2014;174(1):195e201. https://doi.org/10.1016/j.jconrel.2013.11.023.

[70] Peñaloza JP, Márquez-Miranda V, Cabaña-Brunod M, Reyes-Ramírez R, Llancalahuen FM, Vilos C, et al. Intra-

cellular trafﬁcking and cellular uptake mechanism of PHBV nanoparticles for targeted delivery in epithelial cell

lines. Journal of Nanobiotechnology 2017;15(1):1e15.

[71] Tahara K, Yamamoto H, Kawashima Y. Cellular uptake mechanisms and intracellular distributions of polysor-

bate 80-modiﬁed poly (d,l-lactide-co-glycolide) nanospheres for gene delivery. European Journal of Pharma-

ceutics and Biopharmaceutics 2010;75(2):218e24. https://doi.org/10.1016/j.ejpb.2010.03.013.

[72] Garaiova Z, Strand SP, Reitan NK, Lélu S, Størset ST, Berg K, et al. Cellular uptake of DNA-chitosan nanopar-

ticles: the role of clathrin- and caveolae-mediated pathways. International Journal of Biological Macromolecules

2012;51(5):1043e51. https://doi.org/10.1016/j.ijbiomac.2012.08.016.

[73] Khan FH. Chemical hazards of nanoparticles to human and environment (a review). Oriental Journal of Chem-

istry 2013;29(4):1399e408.

[74] Sajid M. Nanomaterials: types, properties, recent advances, and toxicity concerns. Current Opinion in Environ-

mental Science & Health 2022;25:100319. https://doi.org/10.1016/j.coesh.2021.100319.

7. Application of nanomedicine for efﬁcient delivery of herbal bioactives190

https://t.me/med1917

[75] Pal G, Rai P, Pandey A. Green synthesis of nanoparticles: a greener approach for a cleaner future. In: Green

synthesis, characterization and applications of nanoparticles. Elsevier Inc.; 2019. p. 1e26.

[76] Witwer KW, Wolfram J. Extracellular vesicles versus synthetic nanoparticles for drug delivery. Nature Reviews

Materials 2021;6(2):103e6. https://doi.org/10.1038/s41578-020-00277-6.

[77] Jain S, Jain V, Mahajan SC. Lipid based vesicular drug delivery systems. Advances in Pharmacy

2014;2014(i):1e12.

[78] Guimarães D, Cavaco-Paulo A, Nogueira E. Design of liposomes as drug delivery system for therapeutic ap-

plications. International Journal of Pharmaceutics 2021;601:120571. https://doi.org/10.1016/

j.ijpharm.2021.120571.

[79] Pagano L, Gkartziou F, Aiello S, Simonis B, Ceccacci F, Sennato S, et al. Resveratrol loaded in cationic gluco-

sylated liposomes to treat Staphylococcus epidermidis infections. Chemistry and Physics of Lipids March 1,

2022;243:105174.

[80] Jahanfar S, Gahavami M, Khosravi-Darani K, Jahadi M, Mozafari MR. Entrapment of rosemary extract by lipo-

somes formulated by Mozafari method: physicochemical characterization and optimization. Heliyon

2021;7(12):e08632. https://doi.org/10.1016/j.heliyon.2021.e08632.

[81] Wang Y, Ding R, Zhang Z, Zhong C, Wang J, Wang M. Curcumin-loaded liposomes with the hepatic and lyso-

somal dual-targeted effects for therapy of hepatocellular carcinoma. International Journal of Pharmaceutics

June 1, 2021;602:120628.

[82] Pérez JV, Cortés DMM, Gómez YG. Potential use of transethosomes as a transdermal delivery system for me-

tabolites from Chenopodium murale. Materials Today Communications 2022;30:103165. https://doi.org/

10.1016/j.mtcomm.2022.103165.

[83] Andleeb M, Shoaib Khan HM, Daniyal M. Development, characterization and stability evaluation of topical gel

loaded with ethosomes containing Achillea millefolium L. extract. Frontiers in Pharmacology 2021;12:1e11.

[84] Paiva-Santos AC, Silva AL, Guerra C, Peixoto D, Pereira-Silva M, Zeinali M, et al. Ethosomes as nanocarriers

for the development of skin delivery formulations. Pharmaceutical Research 2021.

[85] Mo Y, Duan L, Yang Y, Liu W, Zhang Y, Zhou L, et al. Nanoparticles improved resveratrol brain delivery and

its therapeutic efﬁcacy against intracerebral hemorrhage. Nanoscale 2021;13(6):3827e40.

[86] Hassan ME, Hassan RR, Diab KA, El-Nekeety AA, Hassan NS, Abdel-Wahhab MA. Nanoencapsulation of

thyme essential oil: a new avenue to enhance its protective role against oxidative stress and cytotoxicity of

zinc oxide nanoparticles in rats. Environmental Science & Pollution Research 2021;28(37):52046e63.

[87] Pathania R, Najda A, Chawla P, Kaushik R, Khan MA. Low-energy assisted sodium alginate stabilized Phyl-

lanthus niruri extract nanoemulsion: characterization, in vitro antioxidant and antimicrobial application. Bio-

technol Reports March 1, 2022;33:e00711.

[88] Kour P, Afzal S, Gani A, Zargar MI, Nabi Tak U, Rashid S, et al. Effect of nanoemulsion-loaded hybrid bio-

polymeric hydrogel beads on the release kinetics, antioxidant potential and antibacterial activity of encapsu-

lated curcumin. Food Chemistry May 15, 2022;376:131925.

[89] Song R, Lin Y, Li Z. Ultrasonic-assisted preparation of eucalyptus oil nanoemulsion: process optimization,

in vitro digestive stability, and anti-Escherichia coli activity. Ultrasonics Sonochemistry January 1,

2022;82:105904.

[90] Kumar S, Baldi A, Sharma DK. Characterization and in vitro investigation of antiscabietic effect of phytosomes

assimilating quercetin and naringenin rich fraction of Pistacia integerrima galls extract against Sarcoptes scabiei.

Journal of Drug Delivery Science and Technology January 1, 2022;67:102851.

[91] Varadkar M, Gadgoli C. Preparation and evaluation of wound healing activity of phytosomes of crocetin from

Nyctanthes arbor-tristis in rats. Journal of Traditional and Complementary Medicine July 1, 2022;12(4):354e60.

[92] Hussein RM, Kandeil MA, Mohammed NA, Khallaf RA. Evaluation of the hepatoprotective effect of curcumin-

loaded solid lipid nanoparticles against paracetamol overdose toxicity: role of inducible nitric oxide synthase.

Journal of Liposome Research 2022;32:365e75. https://doi.org/10.1080/08982104.2022.2032737.

[93] Kelidari HR, Moemenbellah-Fard MD, Morteza-Semnani K, Amoozegar F, Shahriari-Namadi M, Saeedi M,

et al. Solid-lipid nanoparticles (SLN)s containing Zataria multiﬂora essential oil with no-cytotoxicity and potent

repellent activity against Anopheles stephensi. Journal of Parasitic Diseases 2021;45(1):101e8. https://doi.org/

10.1007/s12639-020-01281-x.

References 191

https://t.me/med1917

[94] Ramalingam R, Dhand C, Mayandi V, Leung CM, Ezhilarasu H, Karuppannan SK, et al. Core-shell structured

antimicrobial nanoﬁber dressings containing herbal extract and antibiotics combination for the prevention of

bioﬁlms and promotion of cutaneous wound healing. ACS Applied Materials & Interfaces 2021.

[95] Beltzig L, Frumkina A, Schwarzenbach C, Kaina B. Cytotoxic, genotoxic and senolytic potential of native and

micellar curcumin. Nutrients 2021;13(7).

[96] Zhang Y, Li T, Hu Y, Chen J, He Y, Gao X, et al. Co-delivery of doxorubicin and curcumin via cRGD-peptide

modiﬁed PEG-PLA self-assembly nanomicelles for lung cancer therapy. Chinese Chemical Letters May 1,

2022;33(5):2507e11.

[97] Yuan Y, Zhang S, Ma M, Wang D, Xu Y. Encapsulation and delivery of curcumin in cellulose nanocrystals

nanoparticles using pH-driven method. LWT February 1, 2022;155:112863.

[98] Kim GY, Lee Y, Ha J, Han S, Lee M. Engineering exosomes for pulmonary delivery of peptides and drugs to

inﬂammatory lung cells by inhalation. Journal of Controlled Release 2021;330:684e95. https://doi.org/

10.1016/j.jconrel.2020.12.053.

[99] García-Seisdedos D, Babiy B, Lerma M, Casado ME, Martínez-Botas J, Lasunción MA, et al. Curcumin stimu-

lates exosome/microvesicle release in an in vitro model of intracellular lipid accumulation by increasing cer-

amide synthesis. Biochimica et Biophysica Acta (BBA)-Molecular and Cell Biology of Lipids

2020;1865(5):158638. https://doi.org/10.1016/j.bbalip.2020.158638.

[100] Chang C, Meikle TG, Drummond CJ, Yang Y, Conn CE. Comparison of cubosomes and liposomes for the

encapsulation and delivery of curcumin. Soft Matter 2021;17(12):3306e13.

[101] Farag DBE, Yousry C, Al-Mahallawi AM, El-Askary HI, Meselhy MR, AbuBakr N. The efﬁcacy of Origanum

majorana nanocubosomal systems in ameliorating submandibular salivary gland alterations in streptozoto-

cin-induced diabetic rats. Drug Delivery 2022;29(1):62e74. https://doi.org/10.1080/10717544.2021.2018522.

[102] Babaei M, Davoodi J, Dehghan R, Zahiri M, Abnous K, Taghdisi SM, et al. Thermosensitive composite hydrogel

incorporated with curcumin-loaded nanopolymersomes for prolonged and localized treatment of glioma. Jour-

nal of Drug Delivery Science and Technology 2020;59:101885. https://doi.org/10.1016/j.jddst.2020.101885.

[103] Gallien J, Srinageshwar B, Gallo K, Holtgrefe G, Koneru S, Otero PS, et al. Curcumin loaded dendrimers spe-

ciﬁcally reduce viability of glioblastoma cell lines. Molecules 2021. https://doi.org/10.3390/

molecules26196050.

[104] Echeverry SM, Rey D, Valderrama IH, Araujo BV de, Aragón DM. Development of a self-emulsifying drug de-

livery system (SEDDS) to improve the hypoglycemic activity of Passiﬂora ligularis leaves extract. Journal of

Drug Delivery Science and Technology 2021;64.

[105] Wang TC, Appiah B, Bonku EM, Yang ZH, Luo L. Establishment of a propolis ethanolic extract self-microemul-

sifying drug delivery system and its antibacterial activity. Biocatalysis and Agricultural Biotechnology

2021;31:1e7.

[106] Aswar M, Bhalekar M, Trimukhe A, Aswar, U. Self-microemulsifying drug delivery system (SMEDDS) of cur-

cumin attenuates depression in olfactory bulbectomized rats. Heliyon 2020;6(8):e04482. https://doi.org/

10.1016/j.heliyon.2020.e04482.

[107] Liu J, Wang Q, Omari-Siaw E, Adu-Frimpong M, Liu J, Xu X, et al. Enhanced oral bioavailability of bisdeme-

thoxycurcumin-loaded self-microemulsifying drug delivery system: formulation design, in vitro and in vivo

evaluation. International Journal of Pharmaceutics 2020;590(301):119887. https://doi.org/10.1016/

j.ijpharm.2020.119887.

[108] Touitou E, Dayan N, Bergelson L, Godin B, Eliaz M. Ethosomesdnovel vesicular carriers for enhanced deliv-

ery: characterization and skin penetration properties. Journal of Controlled Release 2000;65(3):403e18.

[109] Verma P, Pathak K. Therapeutic and cosmeceutical potential of ethosomes: an overview. Journal of Advanced

Pharmaceutical Technology & Research 2010;1(3):274e82.

[110] Dhiman N, Awasthi R, Sharma B, Kharkwal H, Kulkarni GT. Lipid nanoparticles as carriers for bioactive de-

livery. Frontiers of Chemistry 2021;9.

[111] Bangar, PM. Nisome: as a nano carrier in drug delivery system: A review. International Academic Research

Journal of Internal Medicine &

Public Health, 2021;2(5). https://doi.org/10.47310/iarjimph.2021.v02i05.010.

[112] Lu M, Qiu Q, Luo X, Liu X, Sun J, Wang C, et al. Phyto-phospholipid complexes (phytosomes): A novel strategy

to improve the bioavailability of active constituents. Asian Journal of Pharmaceutical Sciences

2019;14(3):265e74. https://doi.org/10.1016/j.ajps.2018.05.011.

7. Application of nanomedicine for efﬁcient delivery of herbal bioactives192

https://t.me/med1917

[113] Azeez NA, Deepa VS, Sivapriya V. Phytosomes: emergent promising nano vesicular drug delivery system for

targeted tumor therapy. Advances in Natural Sciences: Nanoscience and Nanotechnology 2018;9(3):033001.

https://doi.org/10.1088/2043-6254/aadc50.

[114] Chen RP, Chavda VP, Patel AB, Chen ZS. Phytochemical delivery through transferosome (phytosome): an

advanced transdermal drug delivery for complementary medicines. Frontiers in Pharmacology 2022;13:281.

https://doi.org/10.3389/fphar.2022.850862.

[115] Siani P, Donadoni E, Ferraro L, Re F, Di Valentin C. Molecular dynamics simulations of doxorubicin in sphin-

gomyelin-based lipid membranes. Biochimica et Biophysica Acta (BBA)-Biomembranes 2022;1864(1):183763.

https://doi.org/10.1016/j.bbamem.2021.183763.

[116] Pandita A, Sharma P. Pharmacosomes: an emerging novel vesicular drug delivery system for poorly soluble

synthetic and herbal drugs. ISRN Pharm 2013;2013(3):1e10.

[117] Jain S, Tripathi S, Tripathi PK. Invasomes: potential vesicular systems for transdermal delivery of drug mole-

cules. Journal of Drug Delivery Science and Technology 2021;61:102166. https://doi.org/10.1016/

j.jddst.2020.102166.

[118] Girão LFC, Carvalheiro MC, Ferreira-Silva M, da Rocha SLG, Perales J, Martins MBF, et al. Asp-enzymosomes

with saccharomyces cerevisiae asparaginase ii expressed in pichia pastoris: formulation design and in vitro

studies of a potential antileukemic drug. International Journal of Molecular Sciences 2021;22(20).

[119] Jia Y, Akache B, Agbayani G, Chandan V, Dudani R, Harrison BA, et al. The synergistic effects of sulfated lac-

tosyl archaeol archaeosomes when combined with different adjuvants in a murine model. Pharmaceutics

2021;13(2):1e14.

[120] Yuba E. Liposome-based immunity-inducing systems for cancer immunotherapy. Molecular Immunology

2018;98:8e12. https://doi.org/10.1016/j.molimm.2017.11.001.

[121] Large DE, Abdelmessih RG, Fink EA, Auguste DT. Liposome composition in drug delivery design, synthesis,

characterization, and clinical application. Advanced Drug Delivery Reviews 2021;176:113851. https://doi.org/

10.1016/j.addr.2021.113851.

[122] Szwedowicz U, Łapi



nska Z, Gajewska-Naryniecka A, Choroma



nska A. Exosomes and other extracellular ves-

icles with high therapeutic potential: their applications in oncology, neurology, and dermatology. Molecules

2022;27(4).

[123] Raposo G, Stoorvogel W. Extracellular vesicles: exosomes, microvesicles, and friends. The Journal of Cell

Biology 2013;200(4):373e83.

[124] Kumar V, Kumar R, Jain VK, Nagpal S. Preparation and characterization of nanocurcumin based hybrid viro-

somes as a drug delivery vehicle with enhanced anticancerous activity and reduced toxicity. Scientiﬁc Reports

2021;11(1):1e14. https://doi.org/10.1038/s41598-020-79631-1.

[125] Lopez C, Mériadec C, David-Briand E, Dupont A, Bizien T, Artzner F, et al. Loading of lutein in egg-sphingo-

myelin vesicles as lipid carriers: thermotropic phase behaviour, structure of sphingosome membranes and

lutein crystals. Food Research International 2020;138:109770. https://doi.org/10.1016/j.foodres.2020.109770.

[126] Jin S, Du Z, Guo H, Zhang H, Ren F, Wang P. Novel targeted anti-tumor nanoparticles developed from folic

acid-modiﬁed 2-deoxyglucose. International Journal of Molecular Sciences 2019;20(3).

[127] Szczupak A, Aizik D, Moraïs S, Vazana Y, Barak Y, Bayer EA, et al. The electrosome: a surface-displayed enzy-

matic cascade in a biofuel cell’s anode and a high-density surface-displayed biocathodic enzyme. Nanomate-

rials 2017;7(7).

[128] Dairi N, Ferfera-Harrar H, Ramos M, Garrigós MC. Cellulose acetate/AgNPs-organoclay and/or thymol nano-

biocomposite ﬁlms with combined antimicrobial/antioxidant properties for active food packaging use. Inter-

national Journal of Biological Macromolecules 2019;121:508e23. https://doi.org/10.1016/

j.ijbiomac.2018.10.042.

[129] Massaro M, Riela S. Organo-clay nanomaterials based on halloysite and cyclodextrin as carriers for polyphe-

nolic compounds. Journal of Functional Biomaterials 2018;9(4).

[130] Abosabaa SA, Arafa MG, ElMeshad AN. Hybrid chitosan-lipid nanoparticles of green tea extract as natural

anti-cellulite agent with superior in vivo potency: full synthesis and analysis. Drug Delivery

2021;28(1):2160e76. https://doi.org/10.1080/10717544.2021.1989088.

[131] Ashkbar A, Rezaei F, Attari F, Ashkevarian S. Treatment of breast cancer in vivo by dual photodynamic and

photothermal approaches with the aid of curcumin photosensitizer and magnetic nanoparticles. Scientiﬁc Re-

ports 2020;10(1):1e12.

https://doi.org/10.1038/s41598-020-78241-1.

References 193

https://t.me/med1917

[132] Dutta B, Shelar SB, Rajan V, Checker S, Barick KC, Pandey BN, et al. Gelatin grafted Fe3O4 based curcumin

nanoformulation for cancer therapy. Journal of Drug Delivery Science and Technology 2022;67:102974.

https://doi.org/10.1016/j.jddst.2021.1029.

[133] Senturk F, Cakmak S, Kocum IC, Gumusderelioglu M, Ozturk GG. GRGDS-conjugated and curcuminloaded

magnetic polymeric nanoparticles for the hyperthermia treatment of glioblastoma cells. Colloids and Surfaces

A: Physicochemical and Engineering Aspects 2021;622:126648. https://doi.org/10.1016/j.colsurfa.2021.126648.

[134] Xu ZP, Zeng QH, Lu GQ, Yu AB. Inorganic nanoparticles as carriers for efﬁcient cellular delivery. Chemical

Engineering Science 2006;61(3):1027e40.

[135] Paul W, Sharma CP. Inorganic nanoparticles for targeted drug delivery. In: Biointegration of medical implant

materials. Elsevier Ltd; 2019. p. 333e73.

[136] Xie J, Lee S, Chen X. Nanoparticle-based theranostic agents. Advanced Drug Delivery Reviews

2010;62(11):1064e79. https://doi.org/10.1016/j.addr.2010.07.009.

[137] Malik R, Annapoorni S, Lamba S, Raghavendra Reddy V, Gupta A, Sharma P, et al. Mössbauer and magnetic

studies in nickel ferrite nanoparticles: effect of size distribution. Journal of Magnetism and Magnetic Materials

2010;322(23):3742e7. https://doi.org/10.1016/j.jmmm.2010.07.019.

[138] Solar P, González G, Vilos C, Herrera N, Juica N, Moreno M, et al. Multifunctional polymeric nanoparticles

doubly loaded with SPION and ceftiofur retain their physical and biological properties. Journal of Nanobio-

technology 2015;13(1):1e12.

[139] Xie W, Guo Z, Gao F, Gao Q, Wang D, Liaw BS, et al. Shape-, size-and structure-controlled synthesis and

biocompatibility of iron oxide nanoparticles for magnetic theranostics. Theranostics 2018;8(12):3284. https://

doi.org/10.7150/thno.25220. PMID: 29930730; PMCID: PMC6010979.

[140] Comanescu C. Magnetic nanoparticles: Current advances in nanomedicine, drug delivery and MRI. Chemistry

2022;4(3):872e930. https://doi.org/10.3390/chemistry4030063.

[141] Hayashi K, Nakamura M, Sakamoto W, Yogo T, Miki H, Ozaki S, et al. Superparamagnetic nanoparticle clus-

ters for cancer theranostics combining magnetic resonance imaging and hyperthermia treatment. Theranostics

2013;3(6):366e76.

[142] Kohler N, Sun C, Fichtenholtz A, Gunn J, Fang C, Zhang M. Methotrexate-immobilized poly(ethylene glycol)

magnetic nanoparticles for MR imaging and drug delivery. Small 2006;2(6):785e92.

[143] Solar P, Herrera N, Cea D, Devis S, Gonzalez-Nilo F, Juica N, et al. Physicochemical characterization of PHBV

nanoparticles functionalized with multiple bioactives designed to be theranostics for lung cancer. Journal of

Cluster Science 2020;6.

[144] Vangijzegem T, Lecomte V, Ternad I, Van Leuven L, Muller RN, Stanicki D, et al. Superparamagnetic Iron Ox-

ide Nanoparticles (SPION): From fundamentals to state-of-the-art innovative applications for cancer therapy.

Pharmaceutics 2023.;15:236. https://doi.org/10.3390/pharmaceutics15010236.

[145] Gamarra L, Silva AC, Oliveira TR, Mamani JB, Malheiros SMF, Malavolta L, et al. Application of hyperthermia

induced by superparamagnetic iron oxide nanoparticles in glioma treatment. International Journal of Nanome-

dicine 2011:591.

[146] Torchilin VP. Multifunctional nanocarriers. Advanced Drug Delivery Reviews 2006;58(14):1532e55.

[147] Sun C, Lee JSH, Zhang M. Magnetic nanoparticles in MR imaging and drug delivery. Advanced Drug Delivery

Reviews 2008;60(11):1252e65.

[148] Yang J, Lee CH, Co HJ, Suh HS, Lee K, Huh HM, et al. Multifunctional magneto-polymeric nanohybrids for

targeted detection and synergistic therapeutic effects on breast cancer. 46(46), 8836-8839. Angewandte Chemie

International Edition 2007;46(46):8836e9.

[149] El-Boubbou K, Lemine OM, Ali R, Huwaizi SM, Al-Humaid S, AlKushi A. Evaluating magnetic and thermal

effects of various Polymerylated magnetic iron oxide nanoparticles for combined chemo-hyperthermia. New

Journal of Chemistry 2022;46(12):5489e504. https://doi.org/10.1039/D1NJ05791J.

[150] Hanafy NAN, El-Kemary MA. Silymarin/curcumin loaded albumin nanoparticles coated by chitosan as muco-

inhalable delivery system observing anti-inﬂammatory and anti COVID-19 characterizations in oleic acid trig-

gered lung injury and in vitro COVID-19 experiment. International Journal of Biological Macromolecules

2022;198:101e10. https://doi.org/10.1016/j.ijbiomac.2021.12.073.

[151] Dubey AK, Chaudhry SK, Singh HB, Gupta VK, Kaushik A. Perspectives on nano-nutraceuticals to manage pre

and post COVID-19 infections. Biotechnology Reports 2022:e00712. https://doi.org/10.1016/

j.btre.2022.e00712.

7. Application of nanomedicine for efﬁcient delivery of herbal bioactives194

https://t.me/med1917

[152] Attia GH, Moemen YS, Youns M, Ibrahim AM, Abdou R, El Raey MA. Antiviral zinc oxide nanoparticles medi-

ated by hesperidin and in silico comparison study between antiviral phenolics as anti-SARS-CoV-2. Colloids

Surfaces B Biointerfaces 2021;203:111724. https://doi.org/10.1016/j.colsurfb.2021.111724.

[153] Gunathilake TMSU, Ching YC, Uyama H, Chuah CH. Nanotherapeutics for treating coronavirus diseases. Jour-

nal of Drug Delivery Science and Technology August 1, 2021;64:102634.

[154] Saber-Moghaddam N, Salari S, Hejazi S, Amini M, Taherzadeh Z, Eslami S, et al. Oral nano-curcumin formu-

lation efﬁcacy in management of mild to moderate hospitalized coronavirus disease-19 patients: an open label

nonrandomized clinical trial. Phytotherapy Research 2021;35:2616e23.

[155] Moreno M, Arredondo M, Ramasse QM, McLaren M, Stötzner P, Förster S, et al. ZnO nucleation into trititanate

nanotubes by ALD equipment techniques, a new way to functionalize layered metal oxides. Scientiﬁc Reports

2021;11(1):1e18. https://doi.org/10.1038/s41598-021-86722-0.

[156] Wree JL, Glauber JP, Öhl D, Niesen A, Kostka A, Rogalla D, et al. Sensing and electrocatalytic activity of tung-

sten disulphide thin ﬁlms fabricated via metal-organic chemical vapour deposition. Journal of Materials Chem-

istry C 2021;9(32):10254e65.

[157] Mccullough PA, Grayburn PA, Filardo G, Hall SA, Schussler JM, Stoler RC, et al. Editorial board. The American

Journal of Cardiology 2020;126:iii.

[158] Szilárd Szalay (0000-0002-1214-6811). Available from: https://orcid.org/0000-0002-1214-6811. (Accessed 12

September 2022).

[159] Ding L, Mardazad S, Das S, Szalay S, Schollwöck U, Zimborás Z, et al. Concept of orbital entanglement and

correlation in quantum chemistry. Journal of Chemical Theory and Computation 2021;17(1):79e95.

[160] Ding L, Schilling C. Correlation paradox of the dissociation limit: a quantum information perspective. Journal

of Chemical Theory and Computation 2020;16(7):4159e75.

[161] Moreno M, Zacarias A, Porzel A, Velasquez L, Gonzalez G, Alegría-Arcos M, et al. IR and NMR spectroscopic

correlation of enterobactin by DFT. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy,

2018;198:264e77.

[162] Kaaki K, Hervé-Aubert K, Chiper M, Shkilnyy A, Soucé M, Benoit R, et al. Magnetic nanocarriers of doxoru-

bicin coated with poly(ethylene glycol) and folic acid: relation between coating structure, surface properties,

colloidal stability, and cancer cell targeting. Langmuir 2012;28(2):1496e505. https://pubs.acs.org/doi/pdf/

10.1021/la2037845.

[163] Kievit FM, Stephen ZR, Veiseh O, Arami H, Wang T, Lai VP, et al. Targeting of primary breast cancers and

metastases in a transgenic mouse model using rationally designed multifunctional SPIONs. ACS Nano

2012;(3):2591e601.

[164] Lin JJ, Chen JS, Huang SJ, Ko JH, Wang YM, Chen TL. Folic acidePluronic F127 magnetic nanoparticle clusters

for combined targeting, diagnosis, and therapy applications. Biomaterials 2009;30(28):5114e24.

References 195

https://t.me/med1917

This page intentionally left blank

https://t.me/med1917

Nanophytomedicine:

nanotechnology for herbal product

development and value addition

Akhilesh Tiwari

, Megha Joshi

, Rameshroo Kenwat

Shivani Rai Paliwal

, Kunjbihari Sulakhiya

and

Rishi Paliwal

Department of Pharmacy, Indira Gandhi National Tribal University, Lalpur, Amarkantak,

Madhya Pradesh, India;

Institute of Pharmacy, Vikram University, Ujjain, Madhya Pradesh,

India;

Nanomedicine and Bioengineering Research Laboratory, Department of Pharmacy,

Indira Gandhi National Tribal University, Lalpur, Amarkantak, Madhya Pradesh, India;

Department of Pharmacy, Guru Ghasidas Vishwavidhyalaya (A Central University), Bilaspur,

Chhattisgarh, India

1. Introduction

In traditional practices, plants and herbs are considered an indispensable part of human

life [1]. It is used for preserving and treating human health and is considered to have the ca-

pacity to maintain health in a cost-effective manner with fewer complications [2,3]. Our an-

cestors were well aware of the value of Mother Nature and they established a relationship

between nature and health. However, after urbanization, humans have moved away from na-

ture gradually and this natural method of keeping life healthy has started disappearing.

Although the ancient practice of medicine has well-established application of medicinal

plants which comes from the experience due to ease of application and com mercialization

of modern medical system, this well-established practice got very little promotion for long.

One important factor which was considered for neglecting this system of medicine today is

that it somehow does not have very much physiochemical and biological data, especially

for safety and efﬁcacy. A long-term experience of natural practices with plants by humans

is reported from sanctuaries in many ancient pieces of literature worldwide. Indeed, Indian

CHAPTER

197

Phytopharmaceuticals and Herbal Drugs

https://t.me/med1917

<<< < Предыдущая 10 11 12 13 14 15 16 17 18 19 20 2122 / 4922 23 24 25 26 27 28 29 30 31 32 33 34 > Следующая >>>

Соседние файлы в папке Библиотека им академика М.И. Перельмана

#
10.10.20268 Мб0Книга_5693_Библиотеки_им_академика_М_И_Перельмана.pdf
#
10.10.20268 Мб0Книга_5694_Библиотеки_им_академика_М_И_Перельмана.pdf
#
10.10.20268 Мб0Книга_5695_Библиотеки_им_академика_М_И_Перельмана.pdf
#
10.10.20267 Мб0Книга_5696_Библиотеки_им_академика_М_И_Перельмана.pdf
#
10.10.20267 Мб0Книга_5697_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20267 Мб0Книга_5698_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20267 Мб0Книга_5699_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20266 Мб0Книга_57_библиотеки_им_акад_М_И_Перельмана.pdf
#
30.08.202678 Мб0Книга_570_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20267 Мб0Книга_5700_Библиотеки_им_академика_М_И_Перельмана.pdf
#
12.10.20267 Мб0Книга_5701_Библиотеки_им_академика_М_И_Перельмана.pdf